Barinthus Biotherapeutics plc Financial Flexibility Index
Barinthus Biotherapeutics plc financial flexibility index. Barinthus Biotherapeutics plc (BRNS) has a Financial Flexibility Index of -0.44x as of September 2025. Free cash flow of $-10.73 Million (operating CF $-10.73 Million minus capex $0.00) represents 0% of total liabilities ($24.64 Million). See Barinthus Biotherapeutics plc (BRNS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Barinthus Biotherapeutics plc (2019–2024)
Financial flexibility index of Barinthus Biotherapeutics plc from 2019 to 2024. Historical Financial Flexibility Index trend for Barinthus Biotherapeutics plc across 6 annual periods. Check earnings quality score of Barinthus Biotherapeutics plc to evaluate the quality of earnings relative to operating cash generation.
Barinthus Biotherapeutics plc Financial Flexibility Index by Year (2019–2024)
Barinthus Biotherapeutics plc financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Barinthus Biotherapeutics plc. For the full cash flow conversion analysis, see Barinthus Biotherapeutics plc cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.93x | $-28.05 Million | $-28.94 Million | $30.19 Million | ▲ +43.8% |
| 2023 | -1.65x | $-45.51 Million | $-50.92 Million | $27.51 Million | ▼ -438.7% |
| 2022 | -0.31x | $-8.29 Million | $-14.43 Million | $27.00 Million | ▲ +72.5% |
| 2021 | -1.12x | $-31.44 Million | $-32.58 Million | $28.15 Million | ▼ -459.8% |
| 2020 | -0.20x | $-10.73 Million | $-11.03 Million | $53.81 Million | ▲ +56.0% |
| 2019 | -0.45x | $-18.63 Million | $-18.76 Million | $41.12 Million | — |